Binding molecules for the treatment of myeloid cell...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2526284

The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.

La présente invention concerne une lectine de type C humaine, des molécules de liaison qui se lient spécifiquement à la lectine de type C humaine, des molécules d'acide nucléique codant pour les molécules de liaison ou la lectine de type C humaine, des compositions comprenant les molécules de liaison ou la lectine de type C humaine, ainsi que des procédés pour identifier ou produire les molécules de liaison. La lectine de type C humaine s'exprime de façon spécifique sur des cellules myéloïdes et des molécules de liaison capables de se lier spécifiquement à la lectine de type C humaine, peuvent être utilisées pour le diagnostic, la prévention et/ou le traitement de troubles et de maladies néoplasiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Binding molecules for the treatment of myeloid cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Binding molecules for the treatment of myeloid cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding molecules for the treatment of myeloid cell... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1622121

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.